Article
Novobiocin-induced anti-proliferative and differentiating effects in melanoma B16.
British journal of cancer - 1 Feb 1992
Nordenberg J, Albukrek D, Hadar T, Fux A, Wasserman L, Novogrodsky A, Sidi Y
Abstract excerpt
The antibiotic drug novobiocin was evaluated for its anti-tumour properties in B16 melanoma cells. Novobiocin is shown to inhibit melanoma B16 cell proliferation. The anti-proliferative effect was gradually reversible upon removal of novobiocin from the culture medium. Growth inhibition by novobiocin was accompanied by phenotypic alterations, that included morphological changes, lipid accumulation and marked...
Topics
- Animals
- Antineoplastic Agents
- Cell Count
- Cell Differentiation
- Cell Division
- Drug Screening Assays, Antitumor
- Melanoma, Experimental
- Mycophenolic Acid
- Novobiocin
- Phenotype
- Ribavirin
